MX2010000965A - Productos de farmaco de interferon de liberacion controlada y tratamiento de la infeccion del virus de hepatitis c usando los mismos. - Google Patents
Productos de farmaco de interferon de liberacion controlada y tratamiento de la infeccion del virus de hepatitis c usando los mismos.Info
- Publication number
- MX2010000965A MX2010000965A MX2010000965A MX2010000965A MX2010000965A MX 2010000965 A MX2010000965 A MX 2010000965A MX 2010000965 A MX2010000965 A MX 2010000965A MX 2010000965 A MX2010000965 A MX 2010000965A MX 2010000965 A MX2010000965 A MX 2010000965A
- Authority
- MX
- Mexico
- Prior art keywords
- controlled release
- treatment
- same
- hcv infection
- drug products
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title abstract 2
- 108010050904 Interferons Proteins 0.000 title abstract 2
- 238000013270 controlled release Methods 0.000 title abstract 2
- 229940079322 interferon Drugs 0.000 title abstract 2
- 229940126534 drug product Drugs 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920002988 biodegradable polymer Polymers 0.000 abstract 1
- 239000004621 biodegradable polymer Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000011859 microparticle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención se refiere a formulaciones de liberación controlada que comprenden una micropartícula que comprende un polímero biodegradable y uno o más compuestos de interferón y métodos para usar las formulaciones.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95187907P | 2007-07-25 | 2007-07-25 | |
US95214007P | 2007-07-26 | 2007-07-26 | |
US97833007P | 2007-10-08 | 2007-10-08 | |
US98552607P | 2007-11-05 | 2007-11-05 | |
PCT/US2008/071191 WO2009015336A2 (en) | 2007-07-25 | 2008-07-25 | Controlled release interferon drug products and treatment of hcv infection using same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010000965A true MX2010000965A (es) | 2010-03-09 |
Family
ID=40282165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010000965A MX2010000965A (es) | 2007-07-25 | 2008-07-25 | Productos de farmaco de interferon de liberacion controlada y tratamiento de la infeccion del virus de hepatitis c usando los mismos. |
Country Status (11)
Country | Link |
---|---|
US (1) | US8137661B2 (es) |
EP (1) | EP2175865A4 (es) |
JP (1) | JP2010534681A (es) |
KR (1) | KR20100056479A (es) |
CN (1) | CN101820887A (es) |
AU (1) | AU2008279087A1 (es) |
BR (1) | BRPI0814363A2 (es) |
CA (1) | CA2694440A1 (es) |
MX (1) | MX2010000965A (es) |
WO (1) | WO2009015336A2 (es) |
ZA (1) | ZA201000681B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110229438A1 (en) * | 2008-10-09 | 2011-09-22 | Anadys Pharmaceuticals, Inc. | Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds |
JP2013542983A (ja) | 2010-11-19 | 2013-11-28 | ヴィーナス・レメディーズ・リミテッド | 標的薬物送達のための新規コンジュゲート |
US8809265B2 (en) | 2011-10-21 | 2014-08-19 | Abbvie Inc. | Methods for treating HCV |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
DK2583677T1 (da) | 2011-10-21 | 2015-01-19 | Abbvie Inc | Fremgangsmåder til behandling af HCV omfattende mindst to direktevirkende antivirale midler, ribavirin, men ikke inteferon |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
US20140363396A1 (en) * | 2012-02-01 | 2014-12-11 | Kadmon Pharmaceuticals Llc | Once daily treatment of hepatitis c with ribavirin and taribavirin |
WO2013168179A2 (en) * | 2012-04-03 | 2013-11-14 | Rubicon Research Private Limited | Controlled release pharmaceutical formulations of antiviral agents |
JP7129703B2 (ja) | 2016-04-28 | 2022-09-02 | エモリー ユニバーシティー | アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6410697B1 (en) | 1979-04-20 | 2002-06-25 | Schering Corporation | Process for purifying human leukocyte interferon |
US6835557B1 (en) | 1980-01-08 | 2004-12-28 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides |
US6610830B1 (en) | 1980-07-01 | 2003-08-26 | Hoffman-La Roche Inc. | Microbial production of mature human leukocyte interferons |
US4749576A (en) | 1984-05-10 | 1988-06-07 | Ciba-Geigy Corporation | Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use |
US6387365B1 (en) | 1995-05-19 | 2002-05-14 | Schering Corporation | Combination therapy for chronic hepatitis C infection |
ES2214551T3 (es) | 1995-11-02 | 2004-09-16 | Schering Corporation | Terapia de infusion continua de citocinas a baja dosis. |
US5980948A (en) * | 1996-08-16 | 1999-11-09 | Osteotech, Inc. | Polyetherester copolymers as drug delivery matrices |
KR20010022007A (ko) | 1997-07-18 | 2001-03-15 | 추후보정 | 생물학적 활성 물질의 서방용 생분해성 마크로머 |
US6472373B1 (en) | 1997-09-21 | 2002-10-29 | Schering Corporation | Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection |
EP0903148B1 (en) | 1997-09-21 | 2001-10-10 | Schering Corporation | Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
US6172046B1 (en) | 1997-09-21 | 2001-01-09 | Schering Corporation | Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection |
DE69901321T2 (de) | 1998-05-15 | 2002-12-12 | Schering Corp., Kenilworth | Kombinationstherapie enthaltend Ribavirin und Interferon alpha bei Patienten mit chronischer Hepatitis C Infektion, die nicht antiviral vorbehandelt sind |
US6194006B1 (en) | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
US20030206928A1 (en) | 1999-04-07 | 2003-11-06 | Pertti Tormala | Bioactive, bioabsorbable surgical polyethylene glycol and polybutylene terephtalate copolymer composites and devices |
US6465425B1 (en) | 2000-02-10 | 2002-10-15 | Alkermes Controlled Therapeutics, Inc. | Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins |
DK1305437T3 (da) | 2000-07-31 | 2010-12-13 | Biolex Therapeutics Inc | Ekspression af biologisk aktive polypeptider i andemad |
US7959910B2 (en) | 2000-07-31 | 2011-06-14 | Biolex Therapeutics, Inc. | C-terminally truncated interferon alpha variants |
GB0018968D0 (en) | 2000-08-02 | 2000-09-20 | Pfizer Ltd | Particulate composition |
US7208167B2 (en) * | 2000-08-07 | 2007-04-24 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis C with thymosin and peptide combination therapy |
EP1443907A1 (en) | 2001-11-12 | 2004-08-11 | Alkermes Controlled Therapeutics, Inc. | Biocompatible polymer blends and uses thereof |
JP4471968B2 (ja) | 2003-01-28 | 2010-06-02 | アカデミス ツィーケンホイス ライデン | 毒素に対するll−37由来のペプチド性阻害剤 |
US20050269364A1 (en) | 2004-04-30 | 2005-12-08 | Gibson Rayce D | Inflatable seal for bin discharge system |
EP1621205A1 (en) | 2004-07-28 | 2006-02-01 | OctoPlus Technologies B.V. | Antimicrobial peptides derived from CAP18 |
EP1679065A1 (en) * | 2005-01-07 | 2006-07-12 | OctoPlus Sciences B.V. | Controlled release compositions for interferon based on PEGT/PBT block copolymers |
EP1910279A2 (en) | 2005-06-24 | 2008-04-16 | Migenix Inc. | Non-nucleoside anti-hepacivirus agents and uses thereof |
US8633230B2 (en) * | 2006-01-09 | 2014-01-21 | Jean-Francois Rossignol | Viral hepatitis treatment |
-
2008
- 2008-07-25 KR KR1020107004036A patent/KR20100056479A/ko not_active Application Discontinuation
- 2008-07-25 WO PCT/US2008/071191 patent/WO2009015336A2/en active Application Filing
- 2008-07-25 MX MX2010000965A patent/MX2010000965A/es not_active Application Discontinuation
- 2008-07-25 US US12/180,214 patent/US8137661B2/en not_active Expired - Fee Related
- 2008-07-25 BR BRPI0814363-3A2A patent/BRPI0814363A2/pt not_active IP Right Cessation
- 2008-07-25 JP JP2010518412A patent/JP2010534681A/ja active Pending
- 2008-07-25 EP EP08782397A patent/EP2175865A4/en not_active Withdrawn
- 2008-07-25 AU AU2008279087A patent/AU2008279087A1/en not_active Abandoned
- 2008-07-25 CA CA2694440A patent/CA2694440A1/en not_active Abandoned
- 2008-07-25 CN CN200880109654A patent/CN101820887A/zh active Pending
-
2010
- 2010-01-28 ZA ZA2010/00681A patent/ZA201000681B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2175865A2 (en) | 2010-04-21 |
WO2009015336A3 (en) | 2009-03-19 |
WO2009015336A2 (en) | 2009-01-29 |
EP2175865A4 (en) | 2012-01-11 |
CN101820887A (zh) | 2010-09-01 |
US8137661B2 (en) | 2012-03-20 |
AU2008279087A1 (en) | 2009-01-29 |
US20090068280A1 (en) | 2009-03-12 |
KR20100056479A (ko) | 2010-05-27 |
CA2694440A1 (en) | 2009-01-29 |
JP2010534681A (ja) | 2010-11-11 |
ZA201000681B (en) | 2013-07-31 |
BRPI0814363A2 (pt) | 2015-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010000965A (es) | Productos de farmaco de interferon de liberacion controlada y tratamiento de la infeccion del virus de hepatitis c usando los mismos. | |
TN2010000137A1 (en) | Spiropyrrolidines and their use against hcv and hiv infection | |
ZA200803493B (en) | Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection | |
UA110199C2 (en) | Solid rifaximin dispersion | |
MX2007012157A (es) | Micelas polimericas para suministro de farmacos. | |
EP1753777A4 (en) | METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING HIV INFECTION WITH TRIM5a | |
IN2012DN00971A (es) | ||
PL2217287T3 (pl) | Artykuł do higieny albo pielęgnacji, zawierający część hydroaktywnych polimerów oraz preparat zawierający bakteriofagi albo co najmniej jeden ich składnik | |
AP2009005070A0 (en) | Antiviral drugs for treatment or prevention of dengue infection | |
EP1985283A4 (en) | GELPENDING COMPOSITION FOR USE IN MEDICINE, APPARATUS FOR THE APPLICATION OF THE COMPOSITION, AND MEDICAMENT-RELATED TAX CARRIER | |
MY161495A (en) | Virus like particle compositions and methods of use | |
DE602007009388D1 (de) | Implantierbare medizinprodukte aus verzweigten polymeren | |
IL180947A0 (en) | Vaccine for prevention and treatment of hiv infection | |
DE602007010764D1 (en) | Benzamidglucokinaseaktivatoren | |
WO2008127364A3 (en) | Antiviral compounds and use thereof | |
MX2011008963A (es) | Profarmacos portadores de interferon alfa. | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
TN2011000482A1 (en) | Organic compounds and their uses | |
TNSN08400A1 (en) | Organic compounds and their uses | |
MX2014004862A (es) | Formulaciones de polimero acrilico. | |
PL1998730T3 (pl) | Nowy system uciskowy do leczenia i zapobiegania patologiom pochodzenia żylnego | |
WO2008112390A3 (en) | Terpolymers for controlled release of bioactive agents from implantable medical devices | |
IL202450A (en) | Pharmaceutical composition to treat influenza virus infection | |
IL218277B (en) | Tetracycline compounds, pharmaceutical preparations containing them and their use for the preparation of medicines for the treatment and prevention of infection | |
IL203873A0 (en) | Novel targets and compounds for therapeutic intervention of hiv infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |